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n7344 AspirinInhibitsL-NAMEInducsdPlateletDeposition
onenArterielMedialUnderArterialFlowConditiona
N. Liu, Z. Wang, D. H6bert, J.Y.T.Lam. Montreal Heart Institute, Montreal,
Quebec, Canada
Vascular synthesis and releaea of nitric oxide (NO) have been shown to
inhibit platelet adhesion and aggregation. Inhibition of NO aynthase with L-
NAME can modulate platelet funcfion but whether cotwomitanttreatment with
a platelet inhibitor, aspirin, can alter L-NAME induced alteration of platelet
reactivity is unknown. This was studied in pigs by asaessing 51Cr-labeled
platelet deposition oh an injured arterial media exposed to flowing blood in a
auparfuaion chamber under basal conditions (control), 15 min after L-NAME
lnfuaion (3 mg/kg iv. bolus + 3 m@kr@),and 30 min after L-NAME+aapirin (2
m9k9 of bOkIS)infusion. Arterial blood was drawn from the pigs at a conafent
flow rata through the aupeffusion chamberfor5 rein, underflow conditions of
low ahear rate (SR), 424 a-’, typical of flow in normal unobstructed arteries,
or at a high shear rate of 3397 S-l, typical of flow in stenoaed arteries.
Platelet deposition on the media under the 3 conditions are shown below
GrouP N Plateletdeposition(x I@/cmz)
SR 424s-1 SR 3397 S-l
Control 12 18.1 + 2.8 41.1 + 4.8
L-NAME 12 36.9 * 4.9”* 73.7 i 10.9*
L-NAME + espirin 12 17.9 & 1.8* 45.9 * 4.9t
ANOVA p < 0.001; *p <0.01, l* p < 0.001: controlvs L-NAME; tp <0.05, *p < 0.001:
L-NAME vs L-NAME+ eepirin.
Thus, inhibition of NO syntheais and reledae with L-NAME enhances
platelet reactivity and deposition on an injured arterial surface expoaing
the media ,underboth a low and a high shear rate blood flow condition. This
enhanced platelet reactivity can be inhibited with aspirin. Whetharsepirin can
inhibit platelet hyperreactivity due to endothelial dysfundion and depreaaed
NO ayntheaiaor releaae requirea further atudies.
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m7345 GrapeJuiceButNotOrangeorGrapefruitJuiceSignificantlyInhibitaInVivoPlateletActivityand
ThromboaieinStenoeedCanineCoronaryArteries
J.D. Felts, N. Meelej, H. Osman. Univeraityof Wisconsin-Madiaon,
Madison, W/, USA
Epidemiological atudies show an inverse correlation between the intake
of dietary flavonoids (Fs) and death from coronary artery disease (CAD),
due to antioxidation of LDL cholesterol and reduced platelet aggregation
(PA) by Fs. PA mntributes to both the development of atherosclerosis and
acute platelet thrombus formation (APTF)foIlowed byambolization producing
cyclical flow reductions (CFRS) in stenosed and damaged dog and human
corona~ arferiea. In 7 anesthetized dogs (D) with coronary stenosis and
medial damage, CFRS occurred at 7 + 2/30 min and were abolished after
115 + 13 min by the gastric administration of 10 ml/kg of purpla grape jui~
(GJ). Epinephrine (Epi) 0.2 pgikdmin IV did not renew CFRS in any D. Ex
vivo whole blood PA (mllagen stimulus) was decreased by 47 + II% (p <
0.01) after GJ. In 5 D orange juice (OJ) and 5 D grapefruit juice (GFJ) 10
ml/kg were given. CFRS decreased from 7 + 3 to 6 + 2/30 min (ns) and
from 6 + 2 to 4 * 230 min (ns) after OJ and GFJ, respectively. Ex vivo
PA decreased 12 + 10% (ns) and 17 * 11% (na) after OJ and GFJ. There
was no change in arterial blood preaaure or heart rate from any juice. GJ
contains Fs quercetin, catechins, and anthocyanina, known inhibitors of PA
in vitro, while OJ and GFJ contain less quercetin and primarily Fs naringin,
hesperidin and apigenin glucoside, which produce peer inhibition of PA.The
daily consumption of GJ, with its antioxidants and inhibitors of PA,may have
come of the protection of red wine against the development of CAD, acute
occlusive thrombosis, and myocardial infarction, whareas OJ or GFJ are less
gatad blood flow palteins after stent implantation in a previously deacribad
deep arterial injury, flow-reduced rabbit iliac artery model.
Methods: New Zealand White rabbita treated with aapirfn (ASA) alone (6
mg/k~day for 5 daya), ASA + intravenous heparin or no drugs had either
stainless steel (M) or polymer-coated steel (P) atents (12 x 3 mm, Cook
Inc.) implanted into the iliac arteries. Some polymer-coated aterds were pre-
incubated with anti platelet GP llb/llla antibody (AZl) or antibody-urokinsee
conjugate (AZI-UK) for 24 houra before implantation. Bioal flow waa mea-
aured for 2 hra using trenait-time perivascular flowprobea (Traneonice, NY).
Total occlusion was defined as flow <0.5 ml/min for >10 rein; cyclic flow
variation aa return to flow >0.5 ml/min within 10 min. Resu/ta:
Stent Type n Systemictherapy Occludedn (%) aCFV frsquency(hrl)
Occluded Patard
M s Nil 5 (62.5%) 7.3 * 0.93 2.1 i 2.1
M 12 ASA 9 (75”A) 7.0 + 0.83 4.9 l 1.0
M s ASA +heperin 5 (62.50/.) 6.1 + 0.97 4.3 * 0.s9
P 4 Nil 3 (75%) 6.6 * 1.s 4.0
P 13 ASA 6 (61.5”/n) 7.0 & 0.72 4.7 l 1.s1
P-AZ1 7 ASA 1 (14,3”A) 1.2 0
P-AZ1-UK 6 ASA o 0
al%eoverall (mean+ ad) CFV frequencyin the 31 arteries whichoccluded(6.69+ 1.43)
was significantlyhigherthan the CFVfrequency in the 27veaaelswhich remained patent
(2.32 + 2.47), P <00001.
Cone/usion:A CFVfrequency >5 hrl after atent implantation waa highly
predictive of subsequent arterial occlusion in this model. CFV frequency may
be a useful marker of the afficacy of antiplatelet therapy after stenting.
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1735-1I coronaWRevas~ular,~t,on,npat,entson~hroni~
Dialysis
G.L. Chang, Z.M.B. Ghazzal, W.S. Weintraub, Y. Shen, R. Wakeman,
D.C. Morfia, S.B. King, Ill. Enroty University Atlanta, GA, USA
Patients on chronic dialysis have been reported to have a pcmr outcome
following PTCA or CABG. This report ia the largest series that mmpares
the two revascularization atrategiea. Between 1967 and 1995, 189 patients
were identified from the Emory cardiovascular database who had an initial
PTCA (105 pts, 146 lesions) or CABG (84 pts) while on dialyais, Follow-up
(3-56 mos) was available in 94% of patients. Baaaline characteriatica were
similar between the two groupa with the exception of more class IV CHF (p
< 0.03), left main disease, and less single veasel disease (p e 0.005) in the
CABG group. PTCA angiographic success was 94.5!’. and clinical succeas
(angiogrephic success without complications) was 87.5%. Outcome data are
shown below:
PTCA CABG P Value
In-HospitalEvents
Death s.7% 14.5% NS
Ml 3.O”A 3.2% NS
Stroke 1.0% 4.s% NS
Post DischargeEvents (mean 22 monthe)
Death 530/4 49”/. NS
NonfatalMl 14°%a 6% NS
PTCA 25”A 7% p <0.01
CABG 13% 2% p <0.05
RecurrentAngina 32% 19% NS
likely to be affective. These ara seriously ill patients with a high incidence of in-hospital and
long-term events. Angiograhic follow-up waa available in 55% of patients
9:45 with restenosis seen in 38 of 74 lesions (49%). Conclusion: Chronic diaiyaia
n7346 CyclicFlowVariationFrequencyPredictsArterial patients have a high morbidity and mortality with either PTCA or CABG.Occlusionina RabbitIliacArteryModalof Stent CABG is associated with less additional revascularizationa, a trend to leas
Thrombosis
recurrent angina, but no difference in survival compared to PTCA.
R.K. Aggamal, D.C. Ireland, M.D. Ezekowitz, D.P.de Bono,
A.H. Gershlick. Depafirnent of Cardiology Urriversityof LeicesteL UK,
1 Yale Univeraiw, New Haven, CT USA
Cyclic blood flow variations (CFVS),a marker of platelet thrombus formation,
are known to occur in stenosed arteries with endothelial or medial damage
and may contribute to abrupt vessel occlusion after angioplasty. We investi-
